Vishnu Nayak Badavath

Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19

Suresh Gangadevi, Vishnu Nayak Badavath, Abhishek Thakur et al. · The Journal of Physical Chemistry Letters · 2021 · 97 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis

Vishnu Nayak Badavath, İpek Baysal, Gülberk Uçar et al. · ACS Medicinal Chemistry Letters · 2015 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy

Aye Mya Sithu Shein, Dhammika Leshan Wannigama, Paul G. Higgins et al. · Scientific Reports · 2022 · 53 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (m^pro): a molecular docking, molecular dynamics and structure-activity relationship studies

Vishnu Nayak Badavath, Akhil Kumar, Pralok K. Samanta et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors

Surender Singh Jadav, Suzanne J. F. Kaptein, Ajaykumar Timiri et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 49 citations · Full text

Pharmacy, Chemical Biology, Medicinal Chemistry +11